SCHEMBL289853

SCHEMBL289853

CCCCCCCCCCCCCCCCC1(C(N)=O)CCO1

nearest known ligand 0.56

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170183 1.00 SPHK1 (0.36) SPHK1
Water SCHEMBL7648145 0.98 SPHK1 (0.36) SPHK1
Water SCHEMBL7648077 0.98 SPHK1 (0.36) SPHK1
SCHEMBL11158890 0.85 KDM4E (0.37)
SCHEMBL11156316 0.85 KDM4E (0.37)
SCHEMBL11163555 0.85 KDM4E (0.37)
SCHEMBL11165806 0.85 KDM4E (0.37)
SCHEMBL11465150 0.85 KDM4E (0.37)
SCHEMBL41217 0.84 ALDH1A1 (0.38)
SCHEMBL3260514 0.84 ALDH1A1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7084192-B2 Polylactic acid composite material and molded body Kabushiki Kaisha Toyota Chuo Kankyusho (JP) 2006-08-01 US claimed
US-20240196898-A1 INSANITARY INSECT PEST CONTROL METHOD USING CONDENSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-06-20 US disclosed
EP-2428844-A1 Electrophotographic toner, method of preparing said toner, toner supplying device and image forming apparatus SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-03-14 EP disclosed
US-20110200927-A1 ELECTROPHOTOGRAPHIC TONER SAMSUNG ELECTRONICS CO., LTD (KR) 2011-08-18 US disclosed
US-7084192-B2 Polylactic acid composite material and molded body Kabushiki Kaisha Toyota Chuo Kankyusho (JP) 2006-08-01 US disclosed
US-6942953-B2 Image forming method FUJI XEROX CO., LTD. (JP) 2005-09-13 US disclosed
US-20040253530-A1 Image forming method FUJI XEROX CO., LTD. (JP) 2004-12-16 US disclosed
US-20040054051-A1 Polylactic acid composite material and molded body KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2004-03-18 US disclosed
EP-0882498-B1 Process for producing a solvent-less O/W type emulsion HODOGAYA CHEMICAL CO LTD (JP) 2004-02-11 EP disclosed
EP-0788740-B1 Composite particle aqueous suspension and process for producing same HODOGAYA CHEMICAL CO LTD (JP) 2003-04-16 EP disclosed
US-6153657-A EXCELLENT STABILITY FOR STORAGE AND WATER-DILUTION HODOGAYA CHEMICAL CO., LTD. (JP) 2000-11-28 US disclosed
US-5889088-A Composite particle aqueous suspension and process for producing same HODOGAYA CHEMICAL CO., LTD. (JP) 1999-03-30 US disclosed
EP-0882498-A2 Process for producing a solvent-less O/W type emulsion HODOGAYA CHEMICAL CO LTD (JP) 1998-12-09 EP disclosed
EP-0788740-A1 Composite particle aqueous suspension and process for producing same HODOGAYA CHEMICAL CO LTD (JP) 1997-08-13 EP disclosed
EP-0182253-B1 REFLECTIVE PHOTOGRAPHIC MATERIAL KONICA CORPORATION (JP) 1990-09-05 EP disclosed
EP-0182253-A2 Reflective photographic material KONICA CORPORATION (JP) 1986-05-28 EP disclosed
US-3993838-A Wax or plastic coated phosphor grains THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE INTERIOR (US) 1976-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240196898-A1 INSANITARY INSECT PEST CONTROL METHOD USING CONDENSED HETEROCYCLIC COMPOUND C1S, C1R, CTRC SPHK1 481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.